Retatrutide 20mg Pen Dubai: COA, Clicks & Format Guide
This is the 20mg-format guide: batch RET-20-V-2604-001, 200 clicks at 0.1mg, Janoshik verification, tiered AED pricing, and where the smaller prefilled pen fits against the 30mg pen and 40mg vial.
Update History ▾
The retatrutide 20mg pen is the cleanest fit when a research workflow wants prefilled precision without moving straight to the larger 30mg format. The current route is tied to batch RET-20-V-2604-001 with Janoshik Analytical verification at 99.741% HPLC purity and 20.92 mg assay, each pen delivers 200 clicks at 0.1mg per click, and live pricing runs from AED 1,200 single to AED 1,000 per pen at the 5-pack tier. If the protocol needs more total mass or custom mixing ratios, use the 40mg vial guide; if it needs the flagship 300-click route, move to the 30mg Dubai guide.
What the 20mg Pen Actually Is
The ProPeptide retatrutide 20mg pen is a prefilled triple-agonist research format built around the same molecule discussed in the wider retatrutide literature: LY3437943, a GLP-1 / GIP / glucagon receptor agonist. What changes here is not the molecule, but the delivery architecture researchers are working with.
Instead of a lyophilised vial that needs bacteriostatic water, concentration math, and contamination control during mixing, this format arrives as a sealed 200-click pen. Each click maps to 0.1mg, so the pen carries a total of 20mg with mechanical dose increments already built into the device. That makes it the most straightforward route when the workflow values repeatable click-based handling over reconstitution flexibility.
The current public route is also stronger on proof than many small-format pages in the category: batch RET-20-V-2604-001 is linked to a COA library entry and a Janoshik purity PDF showing 99.741% HPLC purity and 20.92 mg assay.
20mg Pen vs 30mg Pen vs 40mg Vial
The best format depends on whether the protocol prioritises sealed precision, more total clicks, or custom reconstitution ratios. This is the practical split:
| Format | Total Load | Handling Logic | Best Fit |
|---|---|---|---|
| 20mg Pen | 20mg / 200 clicks | 0.1mg per click, no reconstitution | Smaller prefilled route with published batch proof |
| 30mg Pen | 30mg / 300 clicks | 0.1mg per click, no reconstitution | Flagship pen route with more total clicks per device |
| 40mg Vial | 40mg lyophilised | Requires bacteriostatic water and concentration math | Labs that want higher total mass and custom ratios |
In short: the 20mg pen keeps the pen workflow but lowers the total device size, the 30mg Dubai route maximises total clicks in the same sealed format, and the 40mg vial is the route for researchers who are comfortable with a separate reconstitution step.
Prefilled 20mg retatrutide pen — 200 clicks, 99.741% HPLC purity, batch RET-20-V-2604-001.
Open 20mg Product Page →Batch Verification, Click Math & Cost Per mg
The strongest part of this route is that the proof is batch-linked. Janoshik Analytical reports for RET-20-V-2604-001 show 99.741% HPLC purity and 20.92 mg assay, which means the live lot is slightly above the nominal 20mg label claim. That matters because many small-format product pages in this category only publish a headline percentage or no batch identifier at all.
The price ladder is also easy to normalise on a per-milligram basis:
- 1 pen: AED 1,200 total = AED 60/mg
- 3-pack: AED 3,300 total = AED 55/mg
- 5-pack: AED 5,000 total = AED 50/mg
Because the pen uses a 0.1mg-per-click map, click math is simple: 10 clicks = 1mg, 20 clicks = 2mg, 40 clicks = 4mg. For a quicker lookup table that maps the same logic across the larger flagship device, use the retatrutide pen clicks guide.
Delivery, Storage & UAE Handling
The 20mg pen is shipped under the same Dubai cold-chain logic used across the site’s active peptide catalogue. The live product page states same-day Dubai dispatch, next-day other-emirates delivery, and a 2–8°C storage range after receipt.
The key practical difference versus a vial is that the pen is already filled. There is no bacteriostatic-water step, no concentration recalculation, and no open-vial contamination point. That lowers the handling burden substantially. Researchers who need a reconstitution workflow on purpose should use the 40mg vial guide or the broader bacteriostatic water guide.
Under UAE framing, the material is sold for in-vitro laboratory research only. It is not an approved prescription medicine and it is not positioned for human or veterinary use. For the wider legal framing, see Are Peptides Legal in Dubai?
When the 20mg Route Makes the Most Sense
The 20mg pen is the most rational choice when the workflow wants three things at once: a smaller total device size, no reconstitution step, and public batch proof. That combination is what makes it different from the 40mg vial, which carries more total material but asks the lab to do more handling.
It is not automatically the best route for every lab. If the protocol is long enough that the higher total-click capacity matters more than the smaller device, the 30mg pen guide is more efficient. If the lab is optimising around custom concentration ratios or larger total mass per unit, the 40mg vial is the stronger fit.
The 20mg pen is a prefilled research format that delivers 200 total clicks at 0.1mg per click. It removes the reconstitution step and keeps the workflow mechanical rather than syringe-dependent.
Batch RET-20-V-2604-001 is tied to a public Janoshik Analytical purity report showing 99.741% HPLC purity and 20.92 mg assay, with the PDF and related batch records linked from the COA library.
Live pricing is AED 1,200 for one pen, AED 3,300 for a 3-pack, and AED 5,000 for a 5-pack. That works out to AED 60/mg, AED 55/mg, and AED 50/mg respectively.
The pen is sealed, prefilled, and ready to use, while the 40mg vial requires bacteriostatic water and concentration math. The vial offers more total material and more flexible ratios; the pen offers less handling and published batch proof.
No. The 20mg pen is already filled. Researchers store it at 2–8°C and use the click mechanism directly.
Yes. The page is framed for in-vitro laboratory research under UAE MoHAP Circular 17/2022. It is not approved for human or veterinary use.
How We Evaluated This Guide
This page draws on the live 20mg product specifications, the public Janoshik Analytical report for batch RET-20-V-2604-001, published retatrutide trial literature, and UAE research-use compliance framing. We prioritised route-specific facts: total clicks, batch proof, per-milligram pricing, and handling differences against the vial format. Read our editorial policy →
- Jastreboff AM, et al. Triple–Hormone-Receptor Agonist Retatrutide for Obesity. N Engl J Med. 2023;389(6):514–526.
- Coskun T, et al. LY3437943, a novel triple GIP/GLP-1/glucagon receptor agonist for glycaemic control and weight loss. Lancet. 2022;400(10366):1869–1881.
- Janoshik Analytical. Certificate of Analysis for batch RET-20-V-2604-001. Purity PDF.
- Remy Peptides. COA library entry for RET-20-V-2604-001.
- UAE Ministry of Health and Prevention. Circular 17/2022: regulatory framing for research materials.
Retatrutide 20 mg Pen
99.741% HPLC purity, 20.92 mg assay, 200 clicks per pen, and same-day Dubai dispatch.
Open 20mg Product Page →